63 research outputs found

    ν•œκ΅­μΈ μ‘°κΈ° λ₯˜λ§ˆν‹°μŠ€ κ΄€μ ˆμ—Ό ν™˜μžμ—μ„œ λ‹€μ–‘ν•œ 치료 방법에 λ”°λ₯Έ 효과 뢄석

    Get PDF
    μ˜κ³ΌλŒ€ν•™/석사배경: λ₯˜λ§ˆν‹°μŠ€ κ΄€μ ˆμ—Όμ˜ 치료의 μ’…λ₯˜ 및 방법은 점차 λŠ˜μ–΄λ‚˜κ³  μžˆμ§€λ§Œ, κ΄€μ ˆ 손상과 κΈ°λŠ₯ μ €ν•˜λ₯Ό λ§‰λŠ” 졜적의 μΉ˜λ£Œλ²•μ— λŒ€ν•œ μ œμ‹œλŠ” μ—¬μ „νžˆ λšœλ ·ν•˜μ§€ μ•Šλ‹€. 이에 μš°λ¦¬λŠ” ν•œκ΅­μΈ μ‘°κΈ° λ₯˜λ§ˆν‹°μŠ€ κ΄€μ ˆμ—Ό ν™˜μžμ— μ ν•©ν•œ μΉ˜λ£Œλ²•μ„ 밝히고자 4κ°€μ§€μ˜ μ„œλ‘œ λ‹€λ₯Έ 치료 λ°©λ²•μ˜ μž„μƒ 및 방사선학적 κ²°κ³Όλ₯Ό μ—°κ΅¬ν•˜κ³ μž ν•œλ‹€. λŒ€μƒ 및 방법: 195λͺ…μ˜ ν™˜μžλ₯Ό 4개의 μ„œλ‘œ λ‹€λ₯Έ 치료ꡰ: 순차적 초기 λ‹¨μΌμš”λ²• (κ·Έλ£Ή1), 단계적 초기 λ³‘ν•©μš”λ²• (κ·Έλ£Ή2), κ³ μš©λŸ‰ μŠ€ν…Œλ‘œμ΄λ“œμ˜ 단계적 κ°λŸ‰κ³Ό 초기 λ³‘ν•©μš”λ²• (κ·Έλ£Ή3), μ’…μ–‘κ΄΄μ‚¬μΈμž κΈΈν•­μ œμ™€ methotrexate λ³‘ν•©μš”λ²• (κ·Έλ£Ή4)에 λ°°μ •ν•˜μ˜€λ‹€. μž„μƒμ  κ΄€ν•΄(28개의 κ΄€μ ˆ μ§ˆλ³‘ν™œμ„±λ„ 점수<2.6)λ₯Ό λͺ©ν‘œλ‘œ 맀달 평가 ν›„ 치료λ₯Ό μ‘°μ ˆν•˜μ˜€λ‹€. κ²°κ³Ό: 일차적 결과인 건강 평가 섀문은 치료 전을 μ œμ™Έν•˜κ³  각 그룹별 μ‹œκΈ°λ³„ 차이λ₯Ό 보이지 μ•Šμ•˜λ‹€. λ³€ν˜•λœ Sharp/Van der Heijde 방사선 κ΄€μ ˆ μ μˆ˜κ°€ μ•…ν™”λ˜λŠ” ν™˜μžλŠ” κ·Έλ£Ή 4μ—μ„œλ³΄λ‹€ κ·Έλ£Ή 1μ—μ„œ 쒀더 자주 κ΄€μ°°λ˜μ—ˆμœΌλ‚˜, 톡계학적인 μ˜λ―ΈλŠ” μ—†μ—ˆλ‹€ (κ·Έλ£Ή 1μ—μ„œ 25% vs κ·Έλ£Ή 4μ—μ„œ 6%). 이차적 κ²°κ³Όμ˜€λ˜ American College of Rheumatology (ACR) 치료 λ°˜μ‘μ€ 치료 ν›„ 3κ°œμ›” μ§Έ ACR 20, 50이, 6κ°œμ›” μ§Έ ACR 20, 50, 70이 κ·Έλ£Ή 1,2와 κ·Έλ£Ή 3,4간에 μ˜λ―ΈμžˆλŠ” 차이λ₯Ό λ³΄μ˜€μœΌλ‚˜, μ΄λŠ” 6κ°œμ›”μ΄ κ²½κ³Όν•˜λ©° 차이가 μ†Œμ‹€λ˜μ—ˆλ‹€. 치료 ν›„ 1년이 지났을 λ•Œ 각 κ·Έλ£Ήκ°„μ—λŠ” 톡계학적 차이가 μ—†μ—ˆμœΌλ‚˜, λͺ¨λ“  κ΅°μ—μ„œ μ•½ 60%의 κ΄€ν•΄μœ¨μ„ λ³΄μ˜€λ‹€ (각 κ·Έλ£Ή 1-4μ—μ„œ 54%, 61%, 62%, 62%).κ²°λ‘ : ν•œκ΅­μΈ μ‘°κΈ° λ₯˜λ§ˆν‹°μŠ€ κ΄€μ ˆμ—Ό ν™˜μžμ—μ„œ, λšœλ ·ν•œ λͺ©ν‘œμ™€ 집쀑 관찰을 ν•˜λ©° 치료λ₯Ό μ μš©ν•΄ λ‚˜κ°€λ©΄, μΉ˜λ£Œλ²•κ³Ό 상관 없이 높은 λΉ„μœ¨μ˜ μž„μƒμ  κ΄€ν•΄λ₯Ό 이룰 수 μžˆλ‹€.ope

    Takayasu arteritis associated with ulcerative colitis and optic neuritis: First case in Korea

    Get PDF
    Takayasu arteritis (TA) is a chronic vasculitis that affects the aortic arch and its primary branches. Ulcerative colitis (UC) is an inflammatory bowel disease of unknown etiology. Patients diagnosed with both TA and UC have rarely been reported. The pathogenesis of TA and UC is uncertain, but cell-mediated mechanisms play an important role in both diseases, and a genetic factor is thought to have an effect on the coincidence of these two diseases. We herein report a 38-year-old female with TA who had a history of UC with optic neuritis. We believe that this is the first case of the coexistence of TA and UC in Korea.ope

    Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud's phenomenon

    Get PDF
    INTRODUCTION: We investigated how many patients, who presented with Raynaud's phenomenon (RP) and who had not been classified as systemic sclerosis (SSc), would be reclassified as SSc, if the 2013 American College of Rheumatology (ACR)/the European League Against Rheumatism (EULAR) classification criteria were used. We also analyzed the predictive values of the reclassification as SSc in those patients. METHODS: We consecutively enrolled 64 patients with RP and 60 patients with SSc. We applied the new classification criteria to them, reclassified them, and compared variables between those who were newly classified as SSc and those who were not or previously classified as SSc. RESULTS: Seventeen of 64 patients (26.5%), who presented with RP, but did not fulfill the 1980 ACR classification criteria, were newly classified as SSc by the 2013 ACR/EULAR classification criteria. The newly classified patients as SSc showed increased frequencies of sclerodactyly, digital tip ulcer, telangiectasia, abnormal nailfold capillaries and the presence of anti-centromere antibody, compared to those not and telangiectasia and anti-centromere antibody, compared to the previously classified patients. For the reclassification as SSc, the variables with independent predictive value were sclerodactyly (odds ratio (OR) 60.025), telangiectasia (OR 13.353) and the presence of anti-centromere antibody (OR 11.168). CONCLUSIONS: Overall, 26.5% of the patients, who presented with RP, but who did not fulfill the 1980 ACR classification criteria, were newly classified as SSc according to the 2013 ACR/EULAR classification criteria. Sclerodactyly, telangiectasia, and the presence of anti-centromere antibody had independent predictive value for reclassifying patients with RP as SSc.ope

    Ventricular Tachyarrhythmias in a Patient with Andersen-Tawil Syndrome

    Get PDF
    Andersen-Tawil syndrome (ATS), a rare autosomal dominant disorder, is characterized by periodic paralysis, dysmorphic features and cardiac arrhythmias. This syndrome is caused by mutations of KCNJ2 gene, which encodes inward rectifying potassium channel. Here, we report an 18-year-old girl who was presented with life-threatening cardiac arrhythmia and acute respiratory distress. She was diagnosed with ATS, based on dysmorphic features, ventricular arrhythmia, and periodic paralysis. This is the first case to be reported in Korea who experienced a fatal cardiac arrest and respiratory failure caused by ATS.ope

    Successful Prasugrel Rescue Therapy in Clopidogrel Resistant Patients Who Had Recurrent Stent Thrombosis of Drug-Eluting-Stent: The Role of Prasugrel in Clopidogrel Nonresponders

    Get PDF
    Stent thrombosis is a very serious problem after drug-eluting stent (DES) implantation even though its incidence is about or less than 1%. As the clopidogrel resistance is expected to play an important role in the occurrence of stent thrombosis, new anti-platelet agents overcoming this issue can give us another choice. We experienced a case of a 58-year-old male with successful prasugrel rescue therapy in a patient with clopidogrel resistance who had recurrent stent thrombosis following DES implantation.ope

    Differences in Clinical Manifestations and Outcomes between Adult and Child Patients with Henoch-Schonlein Purpura

    Get PDF
    We aimed to investigate differences in clinical manifestations and outcomes between adult and child patients with Henoch-SchΓΆnlein purpura (HSP), and to analyze the factors associated with poor prognosis for HSP nephritis. This retrospective 10-yr study enrolled 160 patients with HSP who visited Severance Hospital. Purpura was mostly detected in lower extremities, but purpura in upper extremities was more frequently observed in adults than children (41.7% vs 19.3%). Children had a greater frequency of arthralgia (55.4% vs 27.1%), while adults had a greater frequency of diarrhea (20% vs 1.6%). Anemia, elevated C-reactive protein, and level of IgA were more frequently observed in adults (25% vs 7.1%, 65.6% vs 38.4%, 26.3% vs 3.5%). Renal involvement in adults was more severe than in children (79.2% vs 30.4%). Chronic renal failure showed a significant difference in outcomes of HSP between adults (10.4%) and children (1.8%) after a follow up period of an average of 27 months. Furthermore, renal insufficiency at diagnosis was significantly related to the progression to chronic renal failure. Our results showed several differences in the clinical features of HSP between adults and children. Adults with HSP had a higher frequency of renal insufficiency and worse renal outcomes than children. Renal insufficiency at diagnosis might be of predictive value for the progression to chronic renal failure in HSP patients.ope

    Typical 18-FDG-PET/CT Findings of Polymyalgia Rheumatica: A Case Report

    Get PDF
    Polymyalgia rheumatica (PMR) is an inflammatory rheumatic condition characterized by generalized pain and morning stiffness in the shoulders, hip girdle, and neck. Since the pathogenesis of PMR is still uncertain, the diagnosis of PMR depends on clinical features. There have been several studies regarding radiological tools for the diagnosis of PMR. Recent studies using 18-FDG-PET showed bursitis, synovitis, uptake in the spinous process and asymptomatic large-vessel vasculitis in PMR patients. However, there was no report on the efficacy of 18-FDG-PET for diagnosis of PMR in Korea. Here, we are first reporting a case of a Korean patient with PMR, who had radiological findings including bursitis, synovitis, uptake in the spinous process and asymptomatic large-vessel vasculitis on 18-FDG-PET/CT.ope

    유기물 ν˜Ήμ€ 반데λ₯΄λ°œμŠ€ 접합을 ν†΅ν•œ 이황화λͺ°λ¦¬λΈŒλ΄ ν¬ν† λ“œλžœμ§€μŠ€ν„°μ˜ 광전기적 νŠΉμ„± 연ꡬ

    Get PDF
    ν•™μœ„λ…Όλ¬Έ(박사)--μ„œμšΈλŒ€ν•™κ΅ λŒ€ν•™μ› :μžμ—°κ³Όν•™λŒ€ν•™ λ¬Όλ¦¬Β·μ²œλ¬Έν•™λΆ€(물리학전곡),2019. 8. 이탁희.λ³Έ ν•™μœ„ λ…Όλ¬Έμ—μ„œλŠ” 이황화 λͺ°λ¦¬λΈŒλ΄ ν¬ν† νŠΈλžœμ§€μŠ€ν„°μ˜ κ΄‘ μ „μžμ  νŠΉμ„±μ— λŒ€ν•΄ 연ꡬλ₯Ό μˆ˜ν–‰ν•˜μ˜€λ‹€. 박사 ν•™μœ„ κ³Όμ •μ—μ„œ 2차원 물질 기반의 포토 νŠΈλžœμ§€μŠ€ν„°μ˜ κ΄‘ μ „μžμ  νŠΉμ„±μ„ 주둜 νƒκ΅¬ν•˜μ˜€λ‹€. 2차원 λ¬Όμ§ˆμ€ μ›μžμŠ€μΌ€μΌμ˜ 얇은 λ‘κ»˜λ‘œ 인해 λ§Žμ€ λΉ›μ˜ 양을 ν‘μˆ˜ν•  수 μ—†κ³  μƒλ‹Ήνžˆ 큰 μ—‘μ‹œν†€ κ²°ν•© μ—λ„ˆμ§€λ₯Ό 가지고 μžˆλ‹€. 이 두 μš”μΈμ€ 2차원 물질 기반의 κ΄‘ κ²€μΆœκΈ°μ˜ κ΄‘ λ°˜μ‘μ„±μ„ μ–΅μ œμ‹œν‚¨λ‹€. κ·ΈλŸ¬λ‚˜ 포토 νŠΈλžœμ§€μŠ€ν„°λŠ” λ“œλž˜μΈ μ „μ•• 및 게이트 전압을 μ΄μš©ν•΄μ„œ κ΄‘ νŠΉμ„±μ„ μ¦ν­μ‹œν‚¬ 수 μžˆλŠ” ꡬ쑰이기 λ•Œλ¬Έμ—, 2차원 물질 기반의 포토 νŠΈλžœμ§€μŠ€ν„°μ˜ κ΄‘ μ „μžμ  νŠΉμ„±μ„ ν–₯μƒμ‹œν‚¬ 수 μžˆλ‹€. λ³Έ ν•™μœ„ λ…Όλ¬Έμ˜ 2μž₯μ—μ„œλŠ” 이황화 λͺ°λ¦¬λΈŒλ΄ ν¬ν† νŠΈλžœμ§€μŠ€ν„°μ˜ κ΄‘ νŠΉμ„± ν–₯μƒμ‹œν‚€λŠ” 연ꡬλ₯Ό μ†Œκ°œν•œλ‹€. 이황화 λͺ°λ¦¬λΈŒλ΄ ν‘œλ©΄μ— μœ κΈ°λ¬Όμ§ˆμ„ μ΄μš©ν•œ ν‘œλ©΄μ²˜λ¦¬λ‘œ κ΄‘ λ°˜μ‘μ„±κ³Ό κ΄‘ μŠ€μœ„μΉ­ νŠΉμ„±μ„ κ°œμ„ μ‹œν‚¬ 수 μžˆμ—ˆλ‹€. κ΄‘ μ „μžμ  νŠΉμ„± μ„±λŠ₯ν–₯상을 μœ„ν•œ μ—°κ΅¬λΏλ§Œ μ•„λ‹ˆλΌ, 이차원 물질의 본질적인 κ΄‘ μ „μžμ  νŠΉμ„±μ— λŒ€ν•΄μ„œ 연ꡬλ₯Ό μˆ˜ν–‰ν•˜μ˜€λ‹€. λ³Έ ν•™μœ„ λ…Όλ¬Έμ˜ 3μž₯μ—μ„œλŠ” 반데λ₯΄λ°œμŠ€ ν—€ν…Œλ‘œ ꡬ쑰λ₯Ό μ΄μš©ν•˜μ—¬ μ œμž‘ν•œ μ™„μ „νžˆ 투λͺ…ν•œ 이황화 λͺ°λ¦¬λΈŒλ΄ ν¬ν† νŠΈλžœμ§€μŠ€ν„°μ˜ λ³Έμ—°μ˜ κ΄‘ μ „μžμ  νŠΉμ„±μ„ μ„€λͺ…ν•˜μ˜€λ‹€. 4μž₯μ—μ„œλŠ” 이황화 λͺ°λ¦¬λΈŒλ΄ 뿐만 μ•„λ‹ˆλΌ, 홀 도핑이 ν……μŠ€ν… λ””μ…€λ ˆλ‚˜μ΄λ“œ 기반의 ν¬ν† νŠΈλžœμ§€μŠ€ν„°μ˜ κ΄‘μ „μž νŠΉμ„±μ— λ―ΈμΉ˜λŠ” 영ν–₯에 λŒ€ν•΄μ„œλ„ μš”μ•½ν•˜μ˜€λ‹€. κ΄‘ μ „μžμ  μ„±λŠ₯을 μ¦ν­ν•˜κΈ° μœ„ν•΄μ„œ μ™ΈλΆ€ μ „κΈ°μž₯을 μ΄μš©ν•˜λŠ” ν¬ν† νŠΈλžœμ§€μŠ€ν„°μ˜ ꡬ쑰적 νŠΉμ„± λ•Œλ¬Έμ—, κ°•ν•œ μ „κΈ°μž₯ λ‚΄μ—μ„œμ˜ 전기적 그리고 κ΄‘ μ „μžμ  νŠΉμ„±μ— λŒ€ν•΄μ„œ 연ꡬλ₯Ό μˆ˜ν–‰ν•˜μ˜€λ‹€. 이황화 λͺ°λ¦¬λΈŒλ΄ νŠΈλžœμ§€μŠ€ν„°κ°€ κ°•ν•œ μ „κΈ°μž₯ λ‚΄μ—μ„œ μ–΄λ–€ 전기적 νŠΉμ„±μ΄ λ‚˜νƒ€λ‚˜λŠ”μ§€μ— λŒ€ν•΄ 연ꡬλ₯Ό μˆ˜ν–‰ν–ˆκ³  ν₯미둜운 ν˜„μƒλ“€μ„ λ°œκ²¬ν–ˆλ‹€. 5μž₯κ³Ό 6μž₯μ—μ„œλŠ” κ°•ν•œ μ „κΈ°μž₯ λ‚΄μ—μ„œ λ°œμƒν•˜λŠ” μ• λ²ŒλŸ°μΉ˜ 항볡 ν˜„μƒκ³Ό 이차원 물질과 κΈ°νŒμ‚¬μ΄μ—μ„œμ˜ μ „μž νŠΈλž©ν˜„μƒμ— λŒ€ν•΄μ„œ μ„€λͺ…ν•˜μ˜€λ‹€.In this thesis, the optoelectronic characteristics of MoS2 phototransistors are mainly studied. The major reason of exploring the optoelectronic characteristics of 2D materials-based phototransistors, not of photodiodes, during my doctorate course is because 2D materials cannot absorb significant amount of light and they have considerably high exciton binding energy, originating from their atomically thin thickness. These features suppress the optoelectronic performance in the perspective of 2D materials-based photodetectors. However, the phototransistor can amplify the photodetection capability by employing the external electric fields, such as drain-source voltage and gate-source voltage. After introduction of my thesis work in Chapter 1, in Chapter 2 I will summarize a research result of improving photosensitivity of MoS2 phototransistors conducted in 2014 as my first research topic. I demonstrated that a surface treatment with organic materials on MoS2 could improve the photoresponsivity and photoswitching characteristics. In addition to the exploration for improving optoelectronic performance, I became interested in the intrinsic optoelectronic characteristics of 2D materials during my doctorate course. In Chapter 3, I summarize the intrinsic optoelectronic characteristics of fully transparent MoS2 phototransistors employing a van der Waals heterostructure. And, in Chapter 4, the effects of p-doping on optoelectronic characteristics of WSe2 phototransistors are explained. Because of the nature of phototransistors using external electric fields for amplifying the optoelectronic performance, I studied the electrical and optoelectronic phenomena of 2D-based phototransistors under the high electric fields. I have discovered the interesting electrical phenomena in MoS2 transistors under the high electric fields in the process of arranging for the experimental setup for studying optoelectronic characteristics. However, I could not finish this research on the optoelectronic characteristics under the high electric fields due to the insufficient time. I summarized the thickness-dependent avalanche breakdown phenomena and charge trapping dynamics under the high electric fields in Chapters 5 and 6.List of Contents Abstract ....................................................................................................... i List of Contents .......................................................................................... ii Chapter 1. Introduction ............................................................................ 8 1.1. Brief introduction of TMDs and MoS2 ............................................... 8 1.2. Optoelectronic characteristics of MoS2 and a MoS2-based heterostructure for enhancing photosensitivity .................................. 9 1.3. Intrinsic optoelectronics of MoS2 phototransistors .......................... 10 1.4. Electrical characteriscitcs of MoS2 under high electric fields .......... 11 1.5. Outline of this thesis ......................................................................... 12 References ............................................................................................... 13 Chapter 2. Optoelectronic characteristics of MoS2 phototransistors via vertical heterostructure with organic material ................. 16 2.1. Introduction ...................................................................................... 17 2.2. Experiments ...................................................................................... 19 2.2.1. Device fabrication process ..................................................... 19 2.3. Results and discussions .................................................................... 20 2.3.1. Electrical chararcteristics of MoS2 FETs ............................. 20 2.3.2. Modulation of threshold voltage via a heterostructure .......... 22 2.3.3. Enhancement of photoresponsive characteristics .................. 26 2.3.4. Improved photoswitching characteristics .............................. 34 2.4. Conclusion ........................................................................................ 38 Figure captions ........................................................................................ 39 References ............................................................................................... 41 Chapter 3. Intrinsic optoelectronic characteristics of MoS2 phototransistors via a fully transparent van der Waalsheterostructure ...................................................................... 45 3.1. Introduction ...................................................................................... 46 3.2. Experiments ...................................................................................... 48 3.2.1. Device fabrication process ..................................................... 48 3.2.2. Electrical and optical characterizations ................................. 49 3.3. Results and discussions .................................................................... 49 3.3.1. Structure and electrical characteristics of transparent MoS2 phototransistors .................................................................... 49 3.3.2. Spectroscopic characteristics of the transparent MoS2 phototransistors ...................................................................... 52 3.3.3. Comparision of the optoelectronic characteristics of MoS2 phototransistors on transparent and opaque substrates .......... 53 3.3.4. Intrinsic optoelectronic characteristics of transparent MoS2 phototransistors under visible light ........................................ 58 3.3.5. Time-resolved photoresponse characteristics in transparent MoS2 phototransisotrs .......................................................... 63 3.4. Conclusion ........................................................................................ 65 Figure captions ........................................................................................ 66 References ............................................................................................... 67 Chapter 4. Effect of facile p-doping on electrical and optoelectronic characteristics of ambipolar WSe2 field-effect transistors 73 4.1. Introduction ...................................................................................... 74 4.2. Experiments ...................................................................................... 75 4.3. Results and discussions .................................................................... 76 4.3.1. Change of electrical and photoswitching characteristics ....... 76 4.3.2. XPS analysis .......................................................................... 83 4.3.3. Photoluminescence analysis .................................................. 84 4.4. Conclusion ........................................................................................ 87 Figure captions ........................................................................................ 88 References ............................................................................................... 89 Chapter 5. Thickness-dependent avalanche breakdown phenomena inMoS2 field effect transistors under high electric fields ...... 93 5.1. Introduction ...................................................................................... 94 5.2. Experiments ...................................................................................... 95 5.2.1. Device fabrication process ..................................................... 95 5.2.2. Electrical and optical characterizations ................................. 96 5.3. Results and discussions .................................................................... 97 5.3.1. Structure and electrical characteristics of MoS2 FETs ........... 97 5.3.2. Effects of lateral electric field, thermal stress caused by Joule heating, and carrier concentration on electrical breakdown in MoS2 FETs ........................................................................... 100 5.3.3. Unique thickness dependency of MoS2 on avalanche multiplication ....................................................................... 104 5.3.4. Temperature dependence of avalanche multiplication in MoS2 FETs ..................................................................................... 108 5.3.5. Comparision of critical electric field with conventional semiconductor materials ...................................................... 110 5.4. Conclusion ...................................................................................... 111 Figure captions ...................................................................................... 112 References ............................................................................................. 114 Chapter 6. Trapped charge modulation at the MoS2/SiO2 interface by lateral electric field in MoS2 field-effect transistors ........ 119 6.1. Introduction .................................................................................... 120 6.2. Experiments .................................................................................... 121 6.2.1. Device fabrication process ................................................... 121 6.2.2. Electrical characterizations .................................................. 122 6.3. Results and discussions .................................................................. 122 6.3.1. Structure and electrical characteristics of MoS2 FETs ......... 122 6.3.2. Charge trapping and detrapping phenomena depending on the VDS measurement range ........................................................ 124 6.3.3. Charge detrapping processes by the multiple VDS sweeps ... 128 6.3.4. The inflence of h-BN buffer layer inserted between MoS2 channel and SiO2 interfaces ................................................. 130 6.4. Conclusion ...................................................................................... 132 Figure captions ...................................................................................... 133 References ............................................................................................. 134 Chapter 7. Summary ............................................................................. 138 κ°μ‚¬μ˜ κΈ€ .............................................................................................. 141Docto

    TM4SF5-의쑴적 κ°„ 상피세포와 λŒ€μ‹μ„Έν¬μ˜ μƒν˜Έκ΄€κ³„μ— μ˜ν•œ κ°„ μ„¬μœ ν™” 연ꡬ

    No full text
    ν•™μœ„λ…Όλ¬Έ(석사)--μ„œμšΈλŒ€ν•™κ΅ λŒ€ν•™μ› :μ•½ν•™λŒ€ν•™ μ•½ν•™κ³Ό,2020. 2. 이정원.λ§Œμ„±μ  κ°„μ§ˆν™˜μ€ 지방간, κ°„μ—Ό 및 μ„¬μœ ν™”/κ²½ν™” 그리고 간암을 ν¬ν•¨ν•˜λ©° λ§Œμ„±μ μΈ 염증 ν™˜κ²½μ΄ μ€‘μš”ν•œ 역할을 ν•˜λŠ” κ²ƒμœΌλ‘œ μ•Œλ €μ Έ μžˆλ‹€. 특히, κ°„ μ„¬μœ ν™”λŠ” λ§Œμ„± κ°„ 손상에 μ˜ν•œ 결과물둜 비가역적인 κ°„ μ„Έν¬μ˜ 손상과 μ—Όμ¦λ°˜μ‘μœΌλ‘œ μΈν•œ μ„Έν¬μ™ΈκΈ°μ§ˆ(Extracellular matrix, ECM)의 좕적에 μ˜ν•΄ μΌμ–΄λ‚œλ‹€. κ°„ μ„¬μœ ν™”μ˜ μ•…ν™”λŠ” 간경화와 κ°„μ•”μœΌλ‘œ 이어지며, ν˜„μž¬κΉŒμ§€ κ°„ μ„¬μœ ν™”μ˜ μ •ν™•ν•œ 진단 방법과 치료 약물에 λŒ€ν•΄μ„œλŠ” 잘 μ•Œλ €μ§„ λ°”κ°€ μ—†λ‹€. 이전 연ꡬ에 λ”°λ₯΄λ©΄ κ°„ μ„¬μœ ν™”κ°€ μ§„ν–‰λœ 마우슀 κ°„ 쑰직과 인간 κ°„ μ„Έν¬μ—μ„œ Tetraspanin superfamily에 μ†ν•˜λŠ” 막 λ‹¨λ°±μ§ˆμΈ Transmembrane 4L 6 superfamily 5(TM4SF5)의 μœ μ „μžμ™€ λ‹¨λ°±μ§ˆμ˜ λ°œν˜„μ΄ μ¦κ°€λ˜μ–΄ μžˆλŠ” κ²ƒμœΌλ‘œ μ•Œλ €μ§„ λ°” μžˆλ‹€. λ”°λΌμ„œ 이λ₯Ό ν† λŒ€λ‘œ λ³Έ μ—°κ΅¬μ—μ„œλŠ” TM4SF5κ°€ κ°„ μ„¬μœ ν™”λ₯Ό μœ λ°œν•˜λŠ” κ³Όμ •μ—μ„œ κ°„ 상피세포와 λŒ€μ‹μ„Έν¬ μ‚¬μ΄μ˜ μƒν˜Έμž‘μš© 및 면역적 ν™˜κ²½μ— λ―ΈμΉ˜λŠ” 영ν–₯에 λŒ€ν•΄ μ•Œμ•„λ³΄κ³ μž ν•˜μ˜€λ‹€. SNU-449 세포와 마우슀 κ°„ 쑰직의 RNA-Sequencing을 톡해, TM4SF5의 λ°œν˜„μ΄ μ¦κ°€ν•˜λ©΄ IL-6의 ν•˜μœ„ μœ μ „μžμ˜ λ°œν˜„ λ˜ν•œ ν•¨κ»˜ μ¦κ°€ν•˜λŠ” 것을 μ•Œ 수 μžˆμ—ˆλ‹€. 그리고 Open databaseλ₯Ό ν†΅ν•΄μ„œ TM4SF5와 CCL20κ³Ό CXCL10 μ–‘μ˜ 상관관계λ₯Ό μ•Œ 수 μžˆμ—ˆλ‹€. 이λ₯Ό λ°”νƒ•μœΌλ‘œ CCL20κ³Ό CXCL10이 TM4SF5 λ°œν˜„μ— μ˜ν•΄ μ‘°μ ˆλ¨μ„ μ•Œ 수 μžˆμ—ˆλ‹€. λ‹€μŒμœΌλ‘œ, CCL20κ³Ό CXCL10의 λ°œν˜„μ„ μ‘°μ ˆν•˜λŠ” IL-6λ₯Ό κ°„ 상피세포에 μ²˜λ¦¬ν•˜μ˜€λ‹€. μ΄λ•Œ, TM4SF5κ°€ λ°œν˜„λ˜μ§€ μ•ŠλŠ” 세포에 λΉ„ν•΄ TM4SF5κ°€ λ°œν˜„λ˜λŠ” μ„Έν¬μ—μ„œ STAT3의 인산화가 μ¦κ°€λ˜μ—ˆμ„ 뿐만 μ•„λ‹ˆλΌ CCL20, CXCL10의 λ°œν˜„μ΄ μ¦κ°€λœλ‹€λŠ” 것을 ν™•μΈν•˜μ˜€λ‹€. IL-6의 μˆ˜μš©μ²΄μ™€ TM4SF5의 물리적인 결합을 μœ„ν•œ 면역침강법을 톡해 IL-6의 μž‘μš©κ³Ό TM4SF5의 λ°œν˜„μ΄ 상관성 μžˆμŒμ„ ν™•μΈν•˜μ˜€λ‹€. μ΄λŸ¬ν•œ μ‘°κ±΄μ—μ„œ TM4SF5의 선택적 μ–΅μ œμ œμΈ TSAHC[4β€²-(p-toluenesulfonylamido)-4-hydroxychalcone]λ₯Ό μ²˜λ¦¬ν•˜μ˜€μ„ 경우 κ°„ 세포 λ‚΄ IL-6 μˆ˜μš©μ²΄μ™€ TM4SF5의 물리적 결합이 μ†Œμ‹€ 되고, CCL20, CXCL10의 λ°œν˜„ μ—­μ‹œ TSAHC의 농도에 의쑴적으둜 κ°μ†Œν•¨μ„ ν™•μΈν•˜μ˜€λ‹€. ν•œνŽΈ, λŒ€μ‹μ„Έν¬λŠ” μ£Όλ³€ ν™˜κ²½μ— 따라 M1(classical) λ˜λŠ” M2(alternative)둜 λΆ„κ·Ήν™”λœλ‹€. M1-λŒ€μ‹μ„Έν¬μ™€ M2-λŒ€μ‹μ„Έν¬μ˜ Conditioned Media(C.M.)을 얻은 λ’€ κ°„ 상피세포에 μ²˜λ¦¬ν•΄ CCL20, CXCL10의 λ°œν˜„μ„ μΈ‘μ •ν•˜κ±°λ‚˜ IL-6 수용체의 항체λ₯Ό ν•¨κ»˜ μ²˜λ¦¬ν•œ μ‹€ν—˜μ„ 톡해 M1-λŒ€μ‹μ„Έν¬μ—μ„œ IL-6κ°€ 뢄비됨을 μ•Œ 수 μžˆμ—ˆλ‹€. 즉, IL-6λŠ” M1-λŒ€μ‹μ„Έν¬μ—μ„œ λΆ„λΉ„λ˜λ©°, κ°„ μƒν”Όμ„Έν¬μ˜ TM4SF5κ°€ IL-6의 μ‹ ν˜Έμ „λ‹¬μ— κ΄€μ—¬ν•΄ κ°„ μƒν”Όμ„Έν¬μ—μ„œ CCL20, CXCL10을 λΆ„λΉ„ν•˜λŠ” κ²ƒμœΌλ‘œ νŒŒμ•…λ˜μ—ˆλ‹€. μ΄λ•Œ TM4SF5κ°€ λ°œν˜„λ˜λŠ” κ°„ μƒν”Όμ„Έν¬λ‘œλΆ€ν„° λΆ„λΉ„λœ CCL20, CXCL10은 M2-λŒ€μ‹μ„Έν¬λ‘œ λΆ„ν™”κ°€ μœ λ„λ˜λŠ” 것을 λ”μš± μ΄‰μ§„ν•˜λŠ” 것을 THP-1κ³Ό Bone-marrow derived macrophage의 M2 marker(Arg-1, Ppar-Ξ³, CD206 λ“±)κ°€ μ¦κ°€ν•œ 것을 톡해 μ•Œ 수 μžˆμ—ˆλ‹€. M2-λŒ€μ‹μ„Έν¬λŠ” Hepatic stellate cell을 ν™œμ„±ν™” μ‹œμΌœ Col1Ξ±1을 μƒμ„±ν•˜λ©°, κ°„ 상피세포λ₯Ό μžκ·Ήν•΄ Laminin Ξ³2의 ν˜•μ„±μ„ μœ λ„ν•˜μ˜€λ‹€. 세포 μˆ˜μ€€μ˜ μ‹€ν—˜ κ²°κ³Όλ₯Ό 동물 μˆ˜μ€€μ—μ„œ ν™•μΈν•˜κΈ° μœ„ν•΄, CCl4 μ²˜λ¦¬μ— μ˜ν•΄ κ°„ μ„¬μœ ν™”κ°€ μœ λ„λœ 마우슀 λͺ¨λΈμ„ κ΅¬μΆ•ν•˜μ—¬ λΆ„μ„ν•˜μ˜€λ‹€. CCl4의 μ²˜λ¦¬λŠ” TM4SF5의 증가와 Plasma ALT, κ°„ 무게/λͺΈλ¬΄κ²Œ λΉ„μœ¨μ˜ 증가λ₯Ό 일으켰으며, μ΄λŠ” κ°„ μ†μƒμ˜ μ§€ν‘œμ΄λ‹€. κ·ΈλŸ¬λ‚˜ CCl4와 TSHACλ₯Ό ν•¨κ»˜ μ²˜λ¦¬ν•˜λ©΄ Plasma ALT, κ°„ 무게/λͺΈλ¬΄κ²Œ λΉ„μœ¨μ΄ 덜 증가 ν•˜κ±°λ‚˜ ꢁ극적으둜 κ°„ 손상이 덜 μΌμ–΄λ‚œ 것을 ν™•μΈν•˜μ˜€λ‹€. 그리고 쑰직 염색과 mRNA level을 톡해 Ξ±-SMA, Collagen1Ξ±1의 λ°œν˜„μ΄ TSAHCλ₯Ό ν•¨κ»˜ μ²˜λ¦¬ν•œ κ·Έλ£Ήμ—μ„œ κ°μ†Œν•œ 것을 ν™•μΈν•˜μ˜€λ‹€. λ˜ν•œ, κ°„μ˜ Ccl20, Cxcl10의 λ°œν˜„μ΄ κ°μ†Œλ˜κ³  이둜 인해 κ°„μœΌλ‘œ μœ μž…λ˜λŠ” λŒ€μ‹μ„Έν¬κ°€ κ°μ†Œν•œ 것을 μ•Œ 수 μžˆμ—ˆλ‹€. ν•œνŽΈ, κ°„ μƒν”Όμ„Έν¬μ˜ TM4SF5와 M1-λŒ€μ‹μ„Έν¬μ— 의쑴적으둜 μ¦κ°€ν•˜λŠ” Ccl20의 κ°„ μ„¬μœ ν™”μ—μ„œμ˜ 역할을 μ•ŒκΈ° μœ„ν•΄ Ccl20 siRNAλ₯Ό μ •λ§₯μ£Όμ‚¬ν•˜κ³  CCl4둜 κ°„ μ„¬μœ ν™”λ₯Ό μœ λ„ν•˜μ˜€λ‹€. κ·Έ κ²°κ³Ό, Ccl20 siRNA을 ν•¨κ»˜ μ²˜λ¦¬ν•œ 그룹이 CCl4만 μ²˜λ¦¬ν•œ 그룹에 λΉ„ν•΄ μ—Όμ¦μ˜ 정도와 ECM의 생성, λŒ€μ‹μ„Έν¬μ˜ μœ μž…μ΄ κ°μ†Œν•œ 것을 쑰직 염색과 mRNA level을 톡해 ν™•μΈν•˜μ˜€λ‹€. 결과적으둜, TM4SF5λ₯Ό λ°œν˜„ν•˜λŠ” μƒν”Όμ„Έν¬λ‘œλΆ€ν„° Ccl20의 λΆ„λΉ„κ°€ TM4SF5-의쑴적 μ„¬μœ ν™”μ— μ€‘μš”ν•¨μ„ 확인할 수 μžˆμ—ˆλ‹€. λ”°λΌμ„œ, 이 연ꡬλ₯Ό 톡해 κ°„ μ„¬μœ ν™” κ³Όμ •μ—μ„œ TM4SF5 의쑴적인 CCL20, CXCL10의 λ°œν˜„, 그에 λ”°λ₯Έ λŒ€μ‹μ„Έν¬ λΆ„κ·Ήν™”μ˜ μ€‘μš”μ„±μ„ μ•Œ 수 μžˆμ—ˆμœΌλ©°, κ°„ μ„¬μœ ν™” κ³Όμ •μ—μ„œ TM4SF5λ₯Ό λ°œν˜„ν•˜λŠ” κ°„ 상피세포와 λŒ€μ‹ μ„Έν¬μ˜ μƒν˜Έμž‘μš©μ„ μ‘°μ ˆν•˜μ—¬ κ°„ μ„¬μœ ν™”λ₯Ό μΉ˜λ£Œν•  수 μžˆλŠ” κ°€λŠ₯성을 μ œμ‹œν•˜μ˜€λ‹€.Chronic liver disease includes fatty liver, hepatitis, fibrosis/cirrhosis in which the inflammatory environment is known to play an important role. In particular, hepatic fibrosis is a consequence of chronic liver damage and is caused by the accumulation of extracellular matrix (ECM) following chronic damage of hepatocytes and thereafter inflammatory reactions. Exacerbation of liver fibrosis leads to cirrhosis and eventually cancer. Therefore, earlier diagnosis and cure of liver fibrosis would be clinically beneficial. The previous researches have shown that expression level of transmembrane 4 L6 superfamily 5 (TM4SF5) in hepatocytes, a membrane protein belonging to the tetraspanin superfamily, increased in fibrotic human and mouse liver tissues. However, the roles of the microenvironment of the TM4SF5-positive hepatocytes in the development of fibrosis has not been examined. Therefore, the aim of this study was to investigate the effect of TM4SF5 on the cross-talk between hepatocytes and macrophages as well as the immune environment which would be involved in the progression of liver fibrosis. RNA-Sequencing of SNU449 cells and mice liver tissues without or with TM4SF5 expression showed that the expression of certain cytokine/chemokine genes down-stream of IL-6 increased by the expression of TM4SF5. The open database also showed a positive correlation between TM4SF5 and CCL20/CXCL10, indicating that CCL20 and CXCL10 could be regulated by TM4SF5 expression. Thus, this study has been examined the roles of CCL20 and CXCL10 in the TM4SF5-dependent fibrosis in the liver. First, when IL-6, a representative pro-inflammatory cytokine, was treated to hepatocytes, the phosphorylation of STAT3 was increased in cells expressing TM4SF5 as compared to cells not expressing TM4SF5. Expression of CCL20 and CXCL10, as known as down-stream genes of IL-6, were upregulated by TM4SF5 expression. The physical binding of IL-6 receptor Ξ± with TM4SF5 was confirmed by co-immunoprecipitation, indicating that TM4SF5-positive hepatocytes could be affected by IL-6 signaling, presumably for CCL20 and CXCL10 expression. Under these conditions, treatment of TSAHC [4-(p-toluenesulfonylamido)-4-hydroxychalcone], a specific inhibitor of TM4SF5, disrupted the physical binding of IL-6 receptor Ξ± and TM4SF5 in hepatocytes. In addition, expression of CCL20 and CXCL10 were also gradually reduced by TSAHC treatment in a dose-dependent manner. Macrophages, on the other hand, are polarized into M1 or M2 depending on their surrounding microenvironment. When the conditioned-media (CM) from M1-macrophages or M2-macrophages differentiated from THP-1 monocytes was treated to hepatocytes without or with IL-6 receptor antibody, the expression of CCL20 and CXCL10 in hepatocytes increased via the presumable secretion of IL-6 in M1-macrophages. In other words, IL-6 was secreted from M1-macrophages, and TM4SF5 in hepatocytes were involved in the signaling to synthesize CCL20 and CXCL10 by macrophage IL-6. Furthermore, CCL20 and CXCL10 secreted from TM4SF5-positive hepatocytes promoted the polarization of M2-macrophage, which was confirmed by increases in M2 markers (Arg-1, Ppar-Ξ³, and CD206) in THP-1 and bone-marrow derived macrophage. The CM from M2-macrophages then activated hepatic stellate cells to produce Col1Ξ±1 (collagen 1 chain Ξ±1) mRNA and stimulated hepatocytes to induce the expression of Lamc2 (laminin Ξ³2), suggesting their roles in fibrosis development. To confirm these results using in vivo animal model, a hepatic fibrosis mouse model was induced by Intraperitoneal injection of CCl4. Injection of CCl4 resulted in an increase in TM4SF5, plasma ALT and liver weight to body weight ratio, which were signs of liver damage. However, the injection of CCl4 together with TSHAC resulted in reduction of plasma ALT and liver weight to body weight ratio. Immunohistochemistry (IHC) and qPCR analyses confirmed that the expression of Ξ±-SMA, collagen1 Ξ±1 were higher in the group injected with CCl4, which were declined by additional TSAHC treatment. In addition, it was found that the expression of CCL20 and CXCL10 in the CCl4-induced fibrotic livers were reduced by TSAHC treatment, and importantly the macrophages infiltration into the liver was also the case, too. Because the expression of CCL20 in hepatocytes depended on TM4SF5 expression and M1-macrophages, I wanted to know the significance of CCL20 in liver fibrosis. Ccl20 siRNA was intravenously injected during IP injections with CCl4. As a result, IHC and qPCR showed that the group treated with CCl4 and Ccl20 siRNA reduced degree of inflammation, accumulation of ECM, and infiltration of macrophages, although the group treated with CCl4 alone showed higher levels of them. Thus, secretion of CCL20 in hepatocytes depending on TM4SF5 expression can be important for TM4SF5-dependent fibrosis. Altogether, this study showed that the importance of TM4SF5-dependent expression of CCL20 and CXCL10 and the effect of M2 macrophage polarization in the process of liver fibrosis. It is reasonable that liver fibrosis can be alleviated by regulating the cross-talks of hepatocytes expressing TM4SF5 with macrophages.ABSTRACT 1 INTRODUCTION 6 MATERIALS AND METHODS 9 RESULTS 15 DISCUSSION 39 REFERENCES 43 ꡭ문초둝 47Maste

    자극된 μ„¬μœ μ„Έν¬μ—μ„œ 릴렉신 μœ μ „μž 전달을 μ΄μš©ν•œ 세포증식 및 κ΅μ›μ§ˆ 생성 쑰절

    No full text
    Dept. of Medicine/박사[ν•œκΈ€]μš”μΆ”λΆ€ μ²™μΆ”κ΄€ ν˜‘μ°©μ¦μ—μ„œ ν™©μƒ‰μΈλŒ€μ˜ λΉ„ν›„λŠ” μ£Όμš” μ›μΈμΈμžμ€‘μ˜ ν•˜λ‚˜μ΄λ‹€. 이에 λŒ€ν•œ μ§€κΈˆκΉŒμ§€μ˜ 연ꡬ κ²°κ³Όλ₯Ό 보면 정상적인 ν™©μƒ‰μΈλŒ€μ— λΉ„ν•΄ μ²™μΆ”κ΄€ ν˜‘μ°©μ¦μ—μ„œμ˜ λΉ„ν›„λœ ν™©μƒ‰μΈλŒ€μ—μ„œλŠ” νƒ„μ„±μ„¬μœ μ§ˆμ΄ μ†Œμ‹€λ˜κ³  λ°˜ν” λ˜λŠ” μ„¬μœ ν™”μ— μ˜ν•΄ κ΅μ›μ§ˆμ˜ 양이 μ¦κ°€ν•œλ‹€κ³  μ•Œλ €μ Έ μžˆλ‹€. μ‹ μž₯쑰직, ν˜Ήμ€ κ·Έ μ™Έμ˜ 쑰직의 μ„¬μœ ν™”μ— κ΄€ν•œ μ—¬λŸ¬ 가지 μ‹€ν—˜μ  λͺ¨λΈμ—μ„œλ„ 릴렉신은 κ΅μ›μ§ˆμ˜ 생성을 κ°μ†Œμ‹œν‚€κ³  κ΅μ›μ§ˆ λΆ„ν•΄νš¨μ†Œμ˜ 생성을 μ¦κ°€μ‹œν‚€λ©° λ°˜ν”μ˜ μ–‘κ³Ό 정도λ₯Ό κ°μ†Œμ‹œν‚¨λ‹€κ³  μ•Œλ €μ Έ μžˆλ‹€. λ³Έ λ…Όλ¬Έμ—μ„œλŠ” ν™©μƒ‰μΈλŒ€λ‘œλΆ€ν„° μΆ”μΆœν•œ μ„¬μœ μ„Έν¬μ—μ„œ μ„¬μœ ν™”κ°€ μ§„ν–‰λ˜λ„λ‘ μ„¬μœ ν™” μœ λ„ μ„±μž₯인자둜 μžκ·Ήν•œ λ’€ λ‹€μ‹œ 릴렉신 μœ μ „μž 치료λ₯Ό ν–ˆμ„λ•Œ λ‚˜νƒ€λ‚˜λŠ” 생물학적인 λ³€ν™”λ₯Ό μΈ‘μ •ν•˜μ˜€λ‹€. μ„¬μœ μ„Έν¬μ—μ„œ 릴렉신 μœ μ „μžμΉ˜λ£ŒλŠ” 릴렉신 수용체λ₯Ό λ°œν˜„μ‹œν‚€κ³ , μ„Έν¬μ˜ μƒμ‘΄μ—λŠ” 영ν–₯을 λ―ΈμΉ˜μ§€ μ•ŠμœΌλ©°, κ΅μ›μ§ˆμ˜ λΆ„ν•΄λ₯Ό μ¦κ°€μ‹œν‚€λŠ” κ²ƒμœΌλ‘œ λ‚˜νƒ€λ‚¬κ³ , μ„±μž₯인자의 μžκ·Ήμ— μ˜ν•΄ μ„¬μœ ν™”κ°€ μ΄‰μ§„λ˜λ„λ‘ 자극된 μ„¬μœ μ„Έν¬μ—μ„œλ„ κ΅μ›μ§ˆμ˜ 양을 κ°μ†Œμ‹œν‚€λŠ” κ²ƒμœΌλ‘œ λ‚˜νƒ€λ‚¬λ‹€. 릴렉신 μœ μ „μž μΉ˜λ£ŒλŠ” λΉ„ν›„λ˜μ–΄ μžˆλŠ” ν™©μƒ‰μΈλŒ€κ°€ 원인이 λ˜λŠ” μ²™μΆ”κ΄€ ν˜‘μ°©μ¦μ—μ„œ 또 ν•˜λ‚˜μ˜ μ΅œμ†Œ 침슡적 치료의 κ°€λŠ₯성을 μ œμ‹œν•΄μ€„ 수 μžˆμ„ κ²ƒμœΌλ‘œ κΈ°λŒ€λœλ‹€. [영문]Hypertrophied ligamentum flavum(LF), play a major role in the pathogenesis of lumbar spinal stenosis. The previous histological studies showed an increased amount of collagen(scarring or fibrosis), loss of elastic fiber in the thickened LF compared to normal LF. In vitro and in vivo studies, relaxin reduces collagen production, increase procollagenase synthesis and reduce the extent and severity of scarring in a number of experimental models of non-renal and renal fibrosis. We assessed biologic effect of relaxin gene therapy in fibroblast from LF cells which is stimulated by fibrogenic growth factor. Relaxin gene therapy to fibroblast induce the relaxin receptor expression, does not decrease cell survival, increase the degradation of collagen and decrease the collagen content in cultures stimulated with growth factor. Relaxin gene therapy suggest another modality of minimally invasive therapy in lumbar spinal stenosis with hypertrophied ligamentum flavum.ope
    • …
    corecore